Navigation Links
New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting
Date:5/5/2008

- Studies Evaluated Improvement in Symptoms Both in the Short and Long Term

-

WILMINGTON, Del., May 5 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced new study data on SEROQUEL XR(TM) (quetiapine fumarate) Extended-Release Tablets for the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD) in adult patients. The results from the studies were presented today at the 161st Annual Meeting of the American Psychiatric Association (APA) in Washington, DC. In February 2008, the company submitted a supplemental new drug application (sNDA) for SEROQUEL XR for the treatment of MDD as monotherapy, adjunct therapy, and maintenance therapy. AstraZeneca plans to submit a sNDA for SEROQUEL XR for the treatment of GAD, including maintenance of antianxiety effect, during the second quarter of 2008.

The SEROQUEL XR clinical development programs for MDD and GAD included seven Phase III, placebo-controlled studies in MDD as well as four Phase III, placebo-controlled studies in GAD. The three MDD studies presented today investigated SEROQUEL XR in the treatment of adult patients diagnosed with MDD-as monotherapy in both short-term and maintenance treatment and as short- term adjunct treatment versus placebo.(1-3) The two GAD studies presented today investigated treatment with SEROQUEL XR in adult patients diagnosed with GAD-as monotherapy in both short-term and maintenance treatment versus placebo.(4,5) Across all MDD and GAD studies presented today, efficacy with SEROQUEL XR was superior to placebo, as assessed by the primary endpoints. In addition, adverse events reported for SEROQUEL XR in these studies were generally similar to those reported in previous clinical trials with quetiapine (See detailed study data below).(1-5)

MDD affects approximately 15 million American adults and studies have shown that at least one-third of patients with MDD treated with antidepressants fa
'/>"/>

SOURCE AstraZeneca
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression
2. SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia
3. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
4. Keppra XR(TM) Extended-Release Tablets Filed with the FDA
5. UCB Announces Positive Phase III Trial Results for Keppra XR(TM) (levetiracetam) Extended-Release Tablets
6. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
7. Vicus Therapeutics Records Last Patient Visit of Phase 2, VT-122 Trial for the Treatment of Cachexia in Patients With Advanced Lung Cancer
8. Data Show Preoperative Assessment of Breast Cancer Patients Enables Early Diagnosis, Successful Treatment of Lymphedema
9. Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
10. ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment
11. Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... Insulet Corporation (NASDAQ: PODD ), the ... ® Insulin Management System, today announced preliminary revenue ... The Company also announced that it will postpone the ... conference call from Thursday, July 30, as originally scheduled. ... , Preliminary second quarter revenue ...
(Date:7/29/2015)... to data released today by the Centers for Medicare ... D premium is expected to remain stable at $32.50, ... Pharmaceutical Care Management Association (PCMA) said. "The ... spot in American health care. By offering an abundance ... edge, cost-saving tools like pharmacy networks and home delivery ...
(Date:7/29/2015)... , July 29, 2015 Unilife Corporation ... developer, manufacturer and supplier of injectable drug delivery ... platform of instant patch pumps for insulin. ... wearable insulin pump that does not require filling ... prefilled and pre-assembled like an insulin pen, only ...
Breaking Medicine Technology:Insulet Reports Preliminary Second Quarter 2015 Revenue Results 2Insulet Reports Preliminary Second Quarter 2015 Revenue Results 3Insulet Reports Preliminary Second Quarter 2015 Revenue Results 4Insulet Reports Preliminary Second Quarter 2015 Revenue Results 5Unilife Introduces World's First Instant Patch Pump for Insulin 2Unilife Introduces World's First Instant Patch Pump for Insulin 3Unilife Introduces World's First Instant Patch Pump for Insulin 4
(Date:7/29/2015)... ... July 30, 2015 , ... Avid collector, Andrew Hawley from Vintage Rock Posters, ... posters. The same poster art was used for the Charlotte Coliseum show a month ... and are classic boxing style concert posters. , They measure 22 x 28 ...
(Date:7/29/2015)... ... July 29, 2015 , ... According to data released ... Part D premium is expected to remain stable at $32.50, a figure far lower ... Part D program continues to be a bright spot in American health care. By ...
(Date:7/29/2015)... ... July 29, 2015 , ... Sports fans young and old at ... former players of the Detroit Lions, joined by A Forever Recovery, a holistic treatment ... Wide Receiver Herman Moore, Pro Bowl Offensive Lineman Lomas Brown, and Tight End Rob ...
(Date:7/29/2015)... ... July 29, 2015 , ... This past week, CARE Surrogacy Center ... a treasured member of the CARE extended family. , By shedding light on ... parents across the globe gain a newfound perspective on surrogacy in Mexico. The center ...
(Date:7/29/2015)... FL (PRWEB) , ... July 29, 2015 , ... ... have become increasingly aware of the impact drinking and substance abuse is having ... illness. Financial loss is tagged in the billions per year. [1] Will Wesch, ...
Breaking Medicine News(10 mins):Health News:A Forever Recovery Holds Autograph Event with Former Detroit Lions at Cherry Festival 2Health News:Heartfelt Interview Shows Extraordinary Impact of CARE Surrogacy Center Mexico 2Health News:Heartfelt Interview Shows Extraordinary Impact of CARE Surrogacy Center Mexico 3Health News:Workplace Trouble: Survey Reveals Sharp Escalation in Restaurant/Food Service Employee Drug Abuse 2Health News:Workplace Trouble: Survey Reveals Sharp Escalation in Restaurant/Food Service Employee Drug Abuse 3
... the prevention of heart disease and is controlled by ... from Leuven, in Belgium, set out to determine whether ... the reduction of blood pressure that accounts for the ... part of a meta-analysis the team compared blood pressure ...
... here is little benefit in replacing older and cheaper ... treating acute, uncomplicated sinusitis, according to US researchers. Researchers ... to determine whether the symptoms could be treated with ... more expensive (second-line) antibiotics. // ,Dr Jay ...
... a way to make wounds heal at least twice ... team at the Australian University of Technology reports they ... number of key hormones involved in the body's own ... ,The researchers believe that although the complex occurs ...
... undergoing high-dose chemotherapy could be eased by electroacupuncture. Nausea ... fight cancer can prove extremely debilitating for patients. ... to lessen the reaction, but in recent years acupuncture ... help. ,Acupuncture involves the insertion of tiny needles at ...
... you ever applied a hot water bottle to an aching ... ache. This treatment delivered with needlepoint accuracy leads to dramatic ... Heat is a long-established method of bringing relief in lower ... the US have developed a high-tech way of using heat.// ...
... first self-contained artificial heart in a 59-year-old man more ... have installed a second such device in a 70-year-old ... recovering in intensive care at Jewish Hospital in Louisville, ... ,The self-contained mechanical heart, made by Abiomed Inc. of ...
Cached Medicine News:
... MULTIFIRE PREMIUM skin stapler places ... instrument handle is squeezed. The ... and is then formed, thus ... are different sizes of staples, ...
... Appose Single Use Skin Staple Remover ... extractor design that is packaged 12 ... to remove skin staples. The device ... of the extractor under the staple ...
... skin stapler is a full-feature skin stapler ... ,PROXIMATE RH has improved visibility over existing ... ratchet mechanism for easier staple placement., ... patient use instrument designed to deliver rectangular, ...
... linear stapler with LACTOMER™ 9-1 ... is a copolymer of glycolide ... Suture™ ROTICULATOR 55 POLY™ single ... use in abdominal, gynecologic, pediatric ...
Medicine Products: